Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Rimpler is a German skincare and cosmetics company that specializes in the development, production, and distribution of high-quality professional cosmetics. Founded in 1986 by Professor Dr. Manfred Rimpler and Anita Rimpler, the company operates two primary in-house brands: Dr. Rimpler and Isabelle Lancray, Paris. Dr. Rimpler is known for combining natural active ingredients with advanced scientific technologies, such as patented nanostructured lipid carriers (NLC) and liposomes, to enhance skin penetration and efficacy. In addition to its proprietary skincare lines, the company operates a certified pharmaceutical-grade cleanroom facility and offers full-service contract manufacturing (OEM/ODM), packaging, and sterilization services for both the cosmetic and pharmaceutical industries. In May 2022, Dr. Rimpler was acquired by the Dutch nutrition and lifestyle company PS. food & lifestyle to expand its distribution network across Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. Rimpler.